Cygenica
1 known investors
CyGenica develops GEENIE, an engineered protein nanoneedle for intracellular drug delivery that bypasses endosomes to deliver therapeutic molecules such as nucleotides and proteins directly inside cells. The technology targets treatments for cancers and rare disorders and is offered to biopharmaceutical partners.